Stock Market News

5 days Piper Sandler downgrades Biogen, slashes PT by $177 amid transition challenges Investing.com

Piper Sandler downgrades Biogen, slashes PT by $177 amid transition challenges.

Biogen (BIIB)

3 days Biogen Holds On, But Growth Slips Through Its Fingers Seeking Alpha

6 days Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term Zacks

1 week Beaten Down Biogen Stock Looks Attractive At Current Levels Seeking Alpha

3 weeks BMO cuts rating on Merck and Biogen, on lack of near term catalyst Investing.com

3 weeks Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead Investing.com

4 weeks Private Medicare plans must cover Biogen’s ALS drug, US agency says Investing.com

4 weeks Biogen Stock Declines 21.4% in 3 Months: How to Play the Stock Zacks

4 weeks Biogen cut at Jefferies as ‘2025 has a tough setup’ Investing.com

1 month Biogen Inc. (BIIB) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call Transcript Seeking Alpha

2 months Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe Zacks

2 months Here’s Why Biogen Inc. (BIIB) is a Strong Value Stock Zacks

2 months Are Investors Undervaluing Biogen (BIIB) Right Now? Zacks

2 months Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter Seeking Alpha

2 months Biogen Beats on Q3 Earnings & Sales, Raises ’24 EPS View Zacks

2 months Biogen Inc. (BIIB) Q3 2024 Earnings Call Transcript Seeking Alpha

2 months Biogen lifts annual profit forecast as new treatments boost earnings Investing.com

2 months Biogen (NASDAQ:BIIB) Releases FY 2024 Earnings Guidance MarketBeat

2 months Short Interest in Biogen Inc. (NASDAQ:BIIB) Grows By 7.7% MarketBeat

2 months Biogen raises annual profit forecast as new treatments boost earnings Investing.com

2 months Biogen Sinks. Why A Surprise Boost From Its Alzheimer’s Drug Wasn’t Enough. Investor's Business Daily

2 months Alphabet, Biogen, Humana rise premarket; AMD, Eli Lilly fall Investing.com

2 months Biogen (NASDAQ:BIIB) Sees Unusually-High Trading Volume – Here’s What Happened MarketBeat

2 months Greenleaf Trust Sells 3,475 Shares of Biogen Inc. (NASDAQ:BIIB) MarketBeat

2 months Will New Drugs Help Biogen Surpass Q3 Earnings Estimates? Zacks

2 months International Assets Investment Management LLC Has $695.87 Million Stake in Biogen Inc. (NASDAQ:BIIB) MarketBeat

2 months The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen Zacks

3 months The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen Zacks

3 months Biogen Inc. (NASDAQ:BIIB) Shares Bought by Raymond James & Associates MarketBeat

3 months Arlington Partners LLC Acquires 4,902 Shares of Biogen Inc. (NASDAQ:BIIB) MarketBeat